Sign inGet started

McIlvenny Patrick

Insider CIK 1952703 · HZNP Chief Accounting Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
HZNP Horizon Therapeutics Publi D To issuer deriv2023-10-062023-10-062,198— $00SEC↗
HZNP Horizon Therapeutics Publi D To issuer deriv2023-10-062023-10-063,809— $00SEC↗
HZNP Horizon Therapeutics Publi D To issuer deriv2023-10-062023-10-0611,498— $00SEC↗
HZNP Horizon Therapeutics Publi D To issuer2023-10-062023-10-066,874$116.50 $800.8K0SEC↗
HZNP Horizon Therapeutics Publi M Exercise deriv2023-01-052023-01-063,871— $00SEC↗
HZNP Horizon Therapeutics Publi M Exercise deriv2023-01-052023-01-062,198— $02,198SEC↗
HZNP Horizon Therapeutics Publi M Exercise deriv2023-01-052023-01-061,904— $03,809SEC↗
HZNP Horizon Therapeutics Publi F Tax w/h2023-01-052023-01-064,147$113.24 $469.6K6,316SEC↗
HZNP Horizon Therapeutics Publi M Exercise2023-01-052023-01-067,973— $010,463SEC↗
HZNP Horizon Therapeutics Publi A Award deriv2023-01-042023-01-0611,498— $011,498SEC↗